We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Cord Blood America Acquires CorCell

By HospiMedica staff writers
Posted on 25 Oct 2006
Cord Blood America, Inc. More...
(Los Angeles, CA, USA) has acquired the umbilical cord-blood stem-cell preservation company CorCell, Inc. (Philadelphia, PA, USA).

Cord Blood America purchased the operating entity and assets of CorCell on October 13, 2006. In addition, the agreement gives Cord Blood America exclusive rights to make an additional purchase of the current approximately 12,000 customers of CorCell by March 31, 2007. Financial details were not disclosed for either transaction.

CorCell, established in 1995, collects umbilical cord blood stem cells from hospitals in all 50 states as well as internationally. The company has grown its primary business through strategic partnerships with health insurers throughout the United States. CorCell will retain its operating name.

"We have consistently said that accretive acquisitions are the most sensible way to grow in this soon-to-be U.S.$1 billion market,” said Matthew Schissler, CEO of Cord Blood America. "Cord Blood America is very pleased for its shareholders to have acquired this strong, successful private company. This acquisition is very important for our future.”

Cord Blood America is the parent company of CorCell, which facilitates cord-blood stem-cell preservation for expectant parents and their children. Its mission is to be the most respected stem-cell-preservation company in the industry. Collected through a safe and noninvasive process, cord blood stem cells offer a potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, and blood and immune disorders.



Related Links:
Cord Blood America
CorCell

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.